Results

Total Results: 976 records

Showing results for "discussed".

81. Evidence Summary: Syphilis Infection in Nonpregnant Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/syphilis-infection-nonpregnant-adults-adolescents-screening
    September 27, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Syphilis Infection in Nonpregnant Adolescents and Adults: Screening September 27, 2022 Recommendations made by the USPSTF are independent of the U.S. governmen…

82. Archived: Preeclampsia: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/preeclampsia-screening-1996
    January 01, 1996 - Aspirin prophylaxis for the prevention of preeclampsia and its complications is discussed elsewhere (

83. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/t6yV6ZMHngeWgmTsoMMefM
    March 01, 2009 - The meta-analysis of RCTs discussed for the key question on benefits (8) re- ported adverse events with

84. Archived: Final Recommendation Statement: Screening for Depression in Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/depression-in-adults-screening
    January 26, 2016 - One trial in older adults reported paradoxical effects from screening, as previously discussed.

85. Screening for High Blood Pressure: Clinical Summary (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/9uFAXAsAPjmgNPaR2CddwN
    December 01, 2007 - Screening for High Blood Pressure: Clinical Summary Screening for High Blood Pressure: Clinical Summary of U.S. Preventive Services Task Force Recommendation Population Adult General Population1 Recommendation Screen for high blood pressure Grade: A Screening Tests High blo…

86. Evidence Summary: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/genital-herpes-serologic-screening
    February 14, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Genital Herpes Infection: Serologic Screening February 14, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They should not be co…

87. ahrq37a_LungCancer_Sum.qxd (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/VN82XmdDhcK74WtHxWBTqm
    May 01, 2004 - found statistically significant differences; however, interpretation is limited by the screening biases discussed … drawing conclusions from the uncontrolled CT studies is difficult because of the methodological biases discussed

88. Archived: Prostate Cancer: Screening, 2008 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2008
    August 05, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Prostate Cancer: Screening, 2008 August 05, 2008 Recommendations made by the USPSTF are independent of the U.S. government. Th…

89. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
    March 01, 2009 - In the meta-analysis discussed earlier, hemorrhagic strokes were statistically significantly increased … As discussed above, gastrointestinal bleeding risk increases with age.

90. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
    May 15, 2009 - We discussed and settled disagreements about inclusion of an article by consensus; if necessary, we involved … The previously discussed prospective study from China, which we excluded because of population, found

91. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vmHooQ6ABG9CagdUXv2_rx
    August 25, 2021 - transient eleva- tions in liver enzyme or creatine kinase levels is unknown.1,17 In the statin trials discussed … that there were no adverse events.1,17 Multifactorial Dyslipidemia The 2 behavioral counseling trials discussed

92. Screening for Colorectal Cancer: Clinical Summary (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/qSyg242Cz-X9DDwZg6GEhP
    Screening for Colorectal Cancer: Clinical Summary SCREENING FOR COLORECTAL CANCER CLINICAL SUMMARY OF U.S. PREVENTIVE TASK FORCE RECOMMENDATION Population Adults Age 50 to 75* Adults Age 76 to 85 years* Adults Older than 85* Screen with high sensitivity fecal occult blood testing (FOBT), …

93. N3Veybr4Zdhzfqsw3Erlhe (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
    November 01, 2014 - angiography is less commonly used now as a confirmatory test, harms from it occurred in 2 of the pre- viously discussed … The 3 previously discussed RCTs, 8 studies based on additional trials, and 8 cohort studies provided

94. Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High Risk Populations (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkeQEwKRWULreuWecXG8S-
    July 01, 2013 - Important tradeoffs between the eight programs are discussed. … The biennial comparisons generally show the same differences as discussed before with the triennial

95. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - It also recommended that raloxifene and exemestane be discussed as additional options for risk reduction

96. Archived: Final Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan11/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
    December 15, 2012 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing December 15, 2012 Recommendations made by the USPSTF are independe…

97. Screening for HIV: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KWfaboZAt9KKoDMQbLvbbt
    June 20, 2019 - Screening for HIV: Recommendation Statement Screening for HIV: Recommendation Statement U.S. Preventive Services Task Force* This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for HIV infection and the supporting scientific evidence, and updates the 1996 recommen-…

98. PII: S0749-3797(01)00261-6 (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
    January 01, 2001 - Most of these principles have been discussed in other parts of this paper. … if they have an important financial, organizational, or intellectual conflict for each topic being discussed

99. Archived: Final Evidence Summary: Lung Cancer: Screening, May 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary35/lung-cancer-screening-2004
    May 15, 2004 - found statistically significant differences; however, interpretation is limited by the screening biases discussed … drawing conclusions from the uncontrolled CT studies is difficult because of the methodological biases discussed

100. Clinical Summary: Screening for Prostate Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/D2Y537H2WCXLrT82Z2M46u
     Clinical Summary: Screening for Prostate Cancer Clinical Summary: Screening for Prostate Cancer Population Men aged 55 to 69 y Men 70 y and older Recommendation The decision to be screened for prostate cancer should be an individual one. Grade: C Do not screen for prostate cancer. Grade: D …